ANXA2 and breast carcinoma: In order to tell the activity of Anxa2 in NF-κB associated EMT in breast cancer, we first assessed the interaction of Anxa2 with NF-κB p50 subunit in breast cancer MDA-MB-231 and MCF-7 cells by coIP analysis (Figure 1A).